-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VeQ2ToZtDFrrt40BBlACtR9Gelmt8uVnE+6f4CaiIksnEuZ2oX4aYXsQ3vsHssji zkLcdOq+A6h/8501GGBpkw== 0001144204-09-064202.txt : 20091211 0001144204-09-064202.hdr.sgml : 20091211 20091211160539 ACCESSION NUMBER: 0001144204-09-064202 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091208 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20091211 DATE AS OF CHANGE: 20091211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC CENTRAL INDEX KEY: 0001072379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943306718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 091236311 BUSINESS ADDRESS: STREET 1: 7600 WISCONSIN AVE. STREET 2: SUITE 750 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 4256083008 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVE. STREET 2: SUITE 750 CITY: BETHESDA STATE: MD ZIP: 20814 8-K 1 v168797_8-k.htm
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
 
FORM 8-K
 
  
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
  
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) December 8, 2009
 
  
NORTHWEST BIOTHERAPEUTICS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
  
DELAWARE
        
(STATE OR OTHER
  
0-33393
  
94-3306718
JURISDICTION
  
(COMMISSION FILE
  
(I.R.S. EMPLOYER
OF INCORPORATION)
  
NUMBER)
  
IDENTIFICATION NO.)
 
7600 Wisconsin Avenue, Suite 750, Bethesda, MD 20814
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
 
  
REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE (240-497-9024)
 
  
 
(NAME OR FORMER ADDRESS IF CHANGED SINCE LAST REPORT)
 
  
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
TABLE OF CONTENTS
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers
 
SIGNATURE
 
 
 
 
 
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers
 
On December 8, 2009, the Board of Directors of Northwest Biotherapeutics, Inc. (the “Company”) approved the appointment of Robert A. Farmer to the Board of Directors.  Mr. Farmer, a graduate of Dartmouth College and Harvard Law School, currently serves on six other corporate boards. 
 
Mr. Farmer served as the national treasurer of four presidential campaigns, including those of John Kerry, Bill Clinton, Michael Dukakis and John Glenn.  In those roles, he led fundraising of over $800 million.  He served under Ron Brown as treasurer of the Democratic National Committee, and served for eight years as treasurer of the Democratic Governor's Association.  President Clinton appointed Farmer as the United States Consul General to Bermuda, where he served from 1994 to 1999.  Mr. Farmer also had a successful career as an entrepreneur, with hands-on experience in company building.  He built his own publishing company, and sold it in 1983. 


 

 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 December 11, 2009
NORTHWEST BIOTHERAPEUTICS, INC.
  
     
     
 
By  
/s/ Alton Boynton  
  
   
Alton L. Boynton 
  
   
President & Chief Executive Officer
  
 

 

 
 -----END PRIVACY-ENHANCED MESSAGE-----